Unterschiede

Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

--- medizin:offlabelmedikamente:studien [13.12.2025 12:20] – angelegt - Externe Bearbeitung 127.0.0.1
+++ medizin:offlabelmedikamente:studien [13.12.2025 19:03] (aktuell) – [Low Dose Naltrexon (LDN)] sven
@@ Zeile 8: / Zeile 8: @@
   * [[https://doi.org/10.1080/21641846.2019.1692770|Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)]]
   * [[https://doi.org/10.1016/j.clinthera.2023.12.009|Low-dose Naltrexone Improves post–COVID-19 condition Symptoms]]
+  * [[https://pubmed.ncbi.nlm.nih.gov/40458265/|Low-Dose naltrexone restored TRPM3 ion channel function in natural killer cells from long COVID patients]]
 ==== Amifampridin ====
   * [[https://www.cureus.com/articles/218002-reduced-fatigue-symptoms-in-the-post-covid-syndrome-with-amifampridine-a-collective-casuistry-with-double-blind-discontinuation-trials#!/|Reduced Fatigue Symptoms in the Post-COVID Syndrome With Amifampridine: A Collective Casuistry With Double-Blind Discontinuation Trials]]